Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF JANUARY 15, 2026 SAM #8816
SPECIAL NOTICE

65 -- Notice of Intent to Award a Blanket Purchase Agreement to a Single Firm for Sterilely Compounded Pharmaceuticals via 503B Compounding Pharmacies for Gallup Indian Medical Center

Notice Date

1/13/2026 11:12:00 AM
 

Notice Type

Special Notice
 

NAICS

325412 — Pharmaceutical Preparation Manufacturing
 

Contracting Office

NAVAJO AREA INDIAN HEALTH SVC WINDOW ROCK AZ 86515 USA
 

ZIP Code

86515
 

Solicitation Number

IRC-GSUT2-20260002
 

Response Due

1/28/2026 9:00:00 AM
 

Archive Date

02/12/2026
 

Point of Contact

Rodney Brown
 

E-Mail Address

Rodney.Brown@ihs.gov
(Rodney.Brown@ihs.gov)
 

Small Business Set-Aside

NONE No Set aside used
 

Description

The Navajo Area Indian Health Service, Gallup Service Unit in Gallup, NM, intends to award a single Blanket Purchase Agreement (BPA) with Fagron Compounding Services LLC (UEI: F7QNV46N18Q4) doing business as Fagron Sterile Services for sterilely compounded pharmaceuticals from an FDA-designated 503B facility on an as-needed basis. Items include Phenylephrine 100mcg.ml, Succinylcholine 20mg/10ml, LET 5ml syringe, Oxytoxin 30 units in 500ml (sterile to sterile and API), Epinephrine 8mg per 250ml bag (or other strength/volumes of the same medications in IV bags as available and required on an as-needed basis). Products must be sterilely compounded in an FDA approved facility with a beyond use date of at least 30 days from manufacture. The anticipated period of performance is: Base Period: 2/1/2026-1/31/2027 Option Period One: 2/1/2027-1/31/2028 Option Period Two: 2/1/2028-1/31/2029 Option Period Three: 2/1/2029-1/31/2030 Option Period Four: 2/1/2030-1/31/2031 The applicable North American Industry Classification System (NAICS) code assigned to this procurement is 325412- Pharmaceutical Preparation Manufacturing with a small business size standard of 1,300 employees. No further awards will be made unless the need for Gallup Indian Medical Center changes. The prospective BPA identified in this notice is sufficient at this time. The identified vendor has the capability to provide sterilely compounded pharmaceuticals in a 503B facility and market research indicates the vendor is the only source. In accordance with Part 12.201-1(e)(3)(i)(B), BPAs may be established with a single firm from which numerous individual purchases at or below the simplified acquisition threshold will likely be made in a given period. Any other sources that believe they are capable of fulfilling the government requirements as described are encouraged to submit their capability statement, price lists, and catalogs to the point of contact below via email only and no later than 1/28/2026 at 10:00AM (MST). In the event additional BPAs are deemed to be in the best interest of the government, capable vendors may be contacted and be requested to establish a BPA with the Government. This notice of intent is not a request for quotations and a solicitation will not be issued. Primary Point of Contact: Rodney Brown, Contract Specialist Email: Rodney.Brown@ihs.gov
 

Web Link

SAM.gov Permalink
(https://sam.gov/workspace/contract/opp/aba129ebb3f941b0a9992b7af38457b0/view)
 

Place of Performance

Address: Gallup, NM 87301, USA

Zip Code: 87301

Country: USA
 

Record

SN07685052-F 20260115/260113230036 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |